ðə dɹˈʌɡ ɪz mˈɑːɹkɪɾᵻd ɪnðə juːnˈaɪɾᵻd stˈeɪts ˌʌndɚ ðə tɹˈeɪd nˈeɪmz lˈɪvəlˌoʊ ænd zˈaɪpɪtˌæmæɡ, ænd ɪnðə jˌʊɹɹəpˈiən jˈuːniən ænd ɹˈʌʃə ˌʌndɚ ðə tɹˈeɪd nˈeɪm lɪvˈɑːzoʊ.
The drug is marketed in the United States under the trade names Livalo and Zypitamag, and in the European Union and Russia under the trade name Livazo.